To explore the potential role of 4EBP1 in tumor progression, we then evaluated the trends of 4EBP1 expression in different pathological stages across all TCGA cancer types and found an increasing tendency in 4EBP1 expression as the tumor progressed in BLCA, BRCA, HNSC, KIRC, KIRP, LIHC, LUSC, MESO, and THCA (Figures 1A,B,D–I,K). Here, EIF4EBP1 is linked to cancer.